Dr. Lal Path Labs Ltd. has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has submitted a compliance certificate for the quarter ended December 31, 2025, under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by the company's Registrar & Share Transfer Agent (MUFG Intime India), confirms that no demat requests were received during the quarter. It also notes that the company does not hold any physical shares. The filing was signed by Vinay Gujral, Company Secretary & Compliance Officer, on January 7, 2026.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that all of the company's shares are already in dematerialised form and no share conversion requests were processed during the quarter.